The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
Clinical trials offer patients the opportunity to get the newest and most promising cancer treatments, so why do only 5% of adult patients with cancer participate in them? Read about the key barriers that need to be addressed. Read More ›
At age 68, Dan Greene was told the intense pain in his abdomen was likely pancreatic cancer, until further testing determined he had stage IV stomach cancer. Joining a clinical trial gave him a second chance. Read More ›
Combating malnutrition should be at the forefront of cancer care, as studies have shown that up to 80% of patients with cancer are malnourished at some point during their treatment. Dr. Spees describes a new clinical trial focused on improving the nutrition of patients with lung cancer. Read More ›
Catherine North has been living with stage IV (metastatic) breast cancer for more than 5 years. She describes her positive experience in a clinical trial, which she highly recommends to people facing similar circumstances. Read More ›
Dana Dornsife, Founder and CEO of Lazarex Cancer Foundation, examines the importance of cancer clinical trials, noting that only about 5% of patients enrolled in clinical trials are from minority communities, something that needs to change. Read More ›
After a lifetime of treating patients, Dr. David Crouch understood his own illness left little room for optimism as skin cancer returned again and again. As a last resort, he joined a clinical trial of a new immunotherapy that provided him a new lease on life. Today, after 2 years in remission, his mission is to educate people about this cancer and this immunotherapy. Read More ›